Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing blockbuster. The US District Court for the Northern District of West Virginia ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

What does Nifty 200 represent? Represents the performance of 200 large-cap and mid-cap companies listed on the National Stock Exchange (NSE), providing a broader market coverage beyond the Nifty 50..

Honor has been spreading its wings in India with a slew of launches. The company recently introduced the Honor 200 series in the country to expand its portfolio in the mid-range and premium segments.